The Medicinal Chemistry Research Laboratory (PeQuiM) has the following lines of research:
- Planning, synthesis and evaluation of new prototypes of drug candidates against neurodegenerative diseases;
- Synthesis, evaluation and optimization of new drug candidates against leishmaniasis and other neglected diseases;
- Synthesis and evaluation of new ligands against SARS-COV-2 with potential effect against COVID-19;
- Planning, synthesis and evaluation of new anti-inflammatory and antitumor ligands.